FI955415A - MTS-geeni, sen mutaatiot ja menetelmät syövän toteamiseksi MTS-geenisekvenssejä käyttäen - Google Patents

MTS-geeni, sen mutaatiot ja menetelmät syövän toteamiseksi MTS-geenisekvenssejä käyttäen Download PDF

Info

Publication number
FI955415A
FI955415A FI955415A FI955415A FI955415A FI 955415 A FI955415 A FI 955415A FI 955415 A FI955415 A FI 955415A FI 955415 A FI955415 A FI 955415A FI 955415 A FI955415 A FI 955415A
Authority
FI
Finland
Prior art keywords
mts gene
mutations
methods
detecting cancer
mts
Prior art date
Application number
FI955415A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI955415A0 (fi
Inventor
Alexander Kamb
Original Assignee
Myriad Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myriad Genetics Inc filed Critical Myriad Genetics Inc
Publication of FI955415A0 publication Critical patent/FI955415A0/fi
Publication of FI955415A publication Critical patent/FI955415A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI955415A 1994-03-18 1995-11-10 MTS-geeni, sen mutaatiot ja menetelmät syövän toteamiseksi MTS-geenisekvenssejä käyttäen FI955415A (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US21508894A 1994-03-18 1994-03-18
US21458294A 1994-03-18 1994-03-18
US21458194A 1994-03-18 1994-03-18
US22736994A 1994-04-14 1994-04-14
US25193894A 1994-06-01 1994-06-01
PCT/US1995/003316 WO1995025429A1 (fr) 1994-03-18 1995-03-17 Gene mts, mutations desdits genes et procedes de diagnostic du cancer a l'aide de sequences du gene mts

Publications (2)

Publication Number Publication Date
FI955415A0 FI955415A0 (fi) 1995-11-10
FI955415A true FI955415A (fi) 1996-01-09

Family

ID=27539686

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955415A FI955415A (fi) 1994-03-18 1995-11-10 MTS-geeni, sen mutaatiot ja menetelmät syövän toteamiseksi MTS-geenisekvenssejä käyttäen

Country Status (9)

Country Link
EP (1) EP0708592A4 (fr)
JP (1) JPH08510651A (fr)
CN (1) CN1128935A (fr)
AU (1) AU694502B2 (fr)
CA (1) CA2162147A1 (fr)
FI (1) FI955415A (fr)
NO (1) NO954494L (fr)
NZ (1) NZ283539A (fr)
WO (1) WO1995025429A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995019369A1 (fr) 1994-01-14 1995-07-20 Vanderbilt University Procede de detection et de traitement du cancer du sein
US6689561B1 (en) * 1994-04-14 2004-02-10 The Regents Of The University Of California Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
AU724324B2 (en) 1995-07-17 2000-09-14 Board Of Regents, The University Of Texas System p16 expression constructs and their application in cancer therapy
US7163925B1 (en) 1995-07-17 2007-01-16 Board Of Regents, The University Of Texas System p16 expression constructs and their application in cancer therapy
US6586203B1 (en) 1995-09-27 2003-07-01 St. Jude Children's Research Hospital ARF-P19, a novel regulator of the mammalian cell cycle
US5723313A (en) 1995-09-27 1998-03-03 St. Jude Children's Research Hospital ARF-p19, a novel regulator of the mammalian cell cycle
US6407062B1 (en) 1995-09-27 2002-06-18 St. Jude Children's Research Hospital ARF-P19, a novel regulator of the mammalian cell cycle
US6037121A (en) * 1995-12-08 2000-03-14 University Technologies International Inc. DNA sequence encoding a tumor suppressor gene
US6747133B1 (en) 1995-12-08 2004-06-08 University Technologies International Inc. Antibodies against the tumor suppressor gene ING1
US6117633A (en) * 1995-12-08 2000-09-12 University Technologies International Inc. DNA sequence encoding the tumor suppressor gene ING1
US6143522A (en) * 1995-12-08 2000-11-07 University Technologies International, Inc. Methods of modulating apoptosis
US5672508A (en) * 1996-01-23 1997-09-30 Mitotix, Inc. Inhibitors of cell-cycle progression, and uses related thereto
US5891857A (en) * 1996-02-20 1999-04-06 Vanderbilt University Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins
EP0927194A2 (fr) * 1996-04-04 1999-07-07 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Nouveau membre d'une famille de genes de croissance aberrante presents dans de multiples tumeurs
US5876972A (en) * 1996-09-23 1999-03-02 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation
CA2284685A1 (fr) * 1997-03-21 1998-10-01 Board Of Regents, The University Of Texas System Nouvelles compositions de genes noey2 et leurs utilisations
US6177410B1 (en) 1997-12-05 2001-01-23 Vanderbilt University Therapeutic methods for prostate cancer
US6440706B1 (en) 1999-08-02 2002-08-27 Johns Hopkins University Digital amplification
CA2416153A1 (fr) 2000-07-14 2002-01-24 Japan Science And Technology Corporation Genes paralogues rad51 mutants et utilisation de ceux-ci dans une therapie anticancereuse
RU2484096C1 (ru) * 2012-02-08 2013-06-10 Общество с ограниченной ответственностью "Технофарма" ОДНОДОМЕННОЕ АНТИТЕЛО, СПЕЦИФИЧЕСКИ СВЯЗЫВАЮЩЕЕ БЕЛОК S100A4/Mts1, ПРИМЕНЕНИЕ ПОЛУЧЕННОГО АНТИТЕЛА ДЛЯ ДЕТЕКЦИИ ЭТОГО БЕЛКА
RU2732769C1 (ru) * 2020-01-10 2020-09-22 Федеральное государственное бюджетное образовательное учреждение высшего образования "Оренбургский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ прогнозирования высокого риска рецидива у пациенток с IB стадией рака шейки матки, получивших комбинированное лечение
CN114163512A (zh) * 2021-03-24 2022-03-11 深圳市新靶向生物科技有限公司 一种与肝癌驱动基因突变相关的抗原肽组合及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE152629T1 (de) * 1990-07-09 1997-05-15 Res Corp Technologies Inc Diagnose von krebs-metastasen durch das mts-1 gen
WO1994009135A1 (fr) * 1992-10-16 1994-04-28 Cold Spring Harbor Laboratory Reagencement de complexes de cyclines et leurs utilisations
US6211334B1 (en) * 1992-10-16 2001-04-03 Cold Spring Harbor Cell-cycle regulatory proteins, and uses related thereto
US6689561B1 (en) * 1994-04-14 2004-02-10 The Regents Of The University Of California Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment

Also Published As

Publication number Publication date
CN1128935A (zh) 1996-08-14
WO1995025429A1 (fr) 1995-09-28
NO954494L (no) 1996-01-17
CA2162147A1 (fr) 1995-09-28
FI955415A0 (fi) 1995-11-10
AU694502B2 (en) 1998-07-23
AU2186395A (en) 1995-10-09
NO954494D0 (no) 1995-11-08
EP0708592A1 (fr) 1996-05-01
EP0708592A4 (fr) 1997-05-07
NZ283539A (en) 1998-02-26
JPH08510651A (ja) 1996-11-12

Similar Documents

Publication Publication Date Title
FI955415A0 (fi) MTS-geeni, sen mutaatiot ja menetelmät syövän toteamiseksi MTS-geenisekvenssejä käyttäen
DE69734887D1 (de) Tumor findende moleküle, davon abstammende konjugate und verfahren zu deren verwendung
GB9507238D0 (en) Detecting dna sequence variations
NO972535D0 (no) Metoder og apparater for DNA sekvenser og DNA identifikasjon
DE69729672D1 (de) Biosensor
EE9900357A (et) Geenisekvenaator ja meetodid
ID24490A (id) Metode untuk menggunakan dan metode pembuatan tabung oven-pijar
GB9517955D0 (en) Nucleotide sequence detection and analysis
DK0566751T3 (da) DNA-påvisningsmetode
NO992993D0 (no) Sammensmeltet ring substituert med idenylmetallkomplekser og fremgangsmÕte for polymerisering derav
DE69840290D1 (de) Einstellbare rechnergestützte tomographie anlage
FI964423A (fi) DNA-sekvenssit
DE69805853D1 (de) Modifizierte lithium-vanadium-oxidelektrodenmaterialien, produkte und verfahren
FR2715976B1 (fr) Rivets-clous et procédés de mise en Óoeuvre de ceux-ci.
DE69818066D1 (de) Verbessertes detektionsverfahren
DK1083934T3 (da) Genterapifremgangsmåder
ID27089A (id) Aparatus perekaman dan metode perekaman
EP1088105A4 (fr) Detection d'organismes non viraux ayant un arn srp
DE69716328T2 (de) Elektroplattierungsverfahren und Zusammenstellung
AU9767998A (en) Germline mutations in the e-cadherin gene and method for detecting predispos ition to cancer
GB9713666D0 (en) Biosensor materials and methods
ATA92998A (de) Rostfreier stahl
EP1016717A4 (fr) Nouvelle proteine ayant une excellente expression dans le cancer du sang, gene codant cette proteine, anticorps dirigee contre cette derniere et procede de detection de l'expression de cette proteine
AU6550598A (en) Antithrombin protein and dna sequences
FR2768632B1 (fr) Amr detection dosage seringue detection dosage